{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/epistaxis-nosebleeds/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"b82f78a8-0e22-5156-bc34-baaa9c78ee15","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field 47e44bec-15da-4c4b-8f1c-a7f20188e36e --><h2>Evidence exclusion criteria</h2><!-- end field 47e44bec-15da-4c4b-8f1c-a7f20188e36e -->","summary":null,"htmlStringContent":"<!-- begin item 0114ab02-151f-424d-a600-a7f20187a3cf --><!-- begin field 36298b3d-3150-49a4-b877-a7f20188e36e --><h2>Our policy</h2><!-- end field 36298b3d-3150-49a4-b877-a7f20188e36e --><!-- begin field 0fb0b146-0bf1-464d-a157-a7f20188e36e --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 0fb0b146-0bf1-464d-a157-a7f20188e36e --><!-- begin field df871294-990f-41a8-b99c-a7f20188e36e --><h2>Standard exclusions for scoping literature:</h2><!-- end field df871294-990f-41a8-b99c-a7f20188e36e --><!-- begin field ee67806e-8c65-4415-b3bb-a7f20188e36e --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field ee67806e-8c65-4415-b3bb-a7f20188e36e --><!-- begin field 3725d58c-afd9-4620-81f1-a7f20188e36e --><h2>Possible exclusions for reviewed literature:</h2><!-- end field 3725d58c-afd9-4620-81f1-a7f20188e36e --><!-- begin field c93e7784-d13f-4abc-9108-a7f20188e36e --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field c93e7784-d13f-4abc-9108-a7f20188e36e --><!-- end item 0114ab02-151f-424d-a600-a7f20187a3cf -->","topic":{"id":"41f6c6fa-463d-5a28-9ffa-15f68320f0ad","topicId":"4e494407-5d2a-47b0-8980-124980c278b3","topicName":"Epistaxis (nosebleeds)","slug":"epistaxis-nosebleeds","lastRevised":"Last revised in August 2020","chapters":[{"id":"8924b1cb-1830-5e93-a601-5a515e1ef05c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"7267ef2e-a210-5137-a813-dac8e91b1831","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b0e06988-22ae-5f73-bb20-2033460ee20a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fb00e926-a8d3-5ae8-8f15-5dca94fff64d","slug":"changes","fullItemName":"Changes"},{"id":"a4dfa534-2e88-5962-97a7-50f5bc6903c5","slug":"update","fullItemName":"Update"}]},{"id":"182f787a-708c-5014-9591-48eddb54268d","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bcaf0313-1bdc-548f-971f-dc9159fb2738","slug":"goals","fullItemName":"Goals"},{"id":"1820dda9-b7b1-5247-ad00-826f0b3f4c46","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6508b703-ccd2-56fe-b323-3dfd267f6057","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"27ddc66a-0532-592f-be80-40b6581b9e9c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d6beda29-ddc7-569c-8f25-2395cd0b3213","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9b9f6fbd-0722-5dcc-afac-e879fdfc6832","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1c7c7c7b-4f02-5cb0-af91-12ff20526fa7","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6a3ef102-679b-5a9e-9d3d-73b58b70d2ef","slug":"definition","fullItemName":"Definition"},{"id":"05e8d25d-b629-5896-847e-76ab44c33576","slug":"causes","fullItemName":"Causes"},{"id":"7e0e17b8-b890-541e-92b5-0790ae3d08b5","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2624ce06-f85b-541e-a7bb-589ee1197b08","slug":"prognosis","fullItemName":"Prognosis"},{"id":"7f96f0b5-4a51-5413-b0b1-73ea61f581ac","slug":"complications","fullItemName":"Complications"}]},{"id":"eee7ea0d-538e-53b8-bf4c-3333153a7978","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4ac070a5-a9e9-58a1-a125-c8a457f1833a","slug":"assessment","fullItemName":"Assessment"}]},{"id":"662dfd0d-d907-52ea-8d8b-97a3cf464cc7","fullItemName":"Management","slug":"management","subChapters":[{"id":"e0220daa-0b07-5f92-af4d-9530f90352ea","slug":"acute-epistaxis","fullItemName":"Scenario: Acute epistaxis"},{"id":"49c8979b-9af3-5eab-a574-05004fda4a4a","slug":"recurrent-epistaxis","fullItemName":"Scenario: Recurrent epistaxis"}]},{"id":"91147d78-80c8-5364-b3e1-7995b6718b2a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c7a65cbb-e7c2-50f8-b6a2-68a41e1db4cb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"bb7e51c5-d888-5640-8c0b-07c8a505bf48","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3c48404f-ce42-5815-8d02-6dd6ef1ae5f3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b82f78a8-0e22-5156-bc34-baaa9c78ee15","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6093800a-eb2a-53e5-918a-e8f0be8c4ae0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6ce6588e-beaa-5a3b-a424-cfad9a225022","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1343761f-c431-50df-9bd2-a9b600c5e067","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c7a65cbb-e7c2-50f8-b6a2-68a41e1db4cb","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}